课题基金 / 基金详情

Dynamic analysis of antigen, antibody, complement, inflammation and coagulation related to rejection, accommodation and tolerance

Dynamic analysis of antigen, antibody, complement, inflammation and coagulation related to rejection, accommodation and tolerance
与排斥、调节和耐受相关的抗原、抗体、补体、炎症和凝血的动态分析
批准号:
20390340
负责人:
KOBAYASHI Takaaki
金额:
$9.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

KOBAYASHI Takaaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
For the purpose of inducing "accommodation" which is defined as a state in which no graft injury is observed despite the presence of anti-donor antibody, after ABO blood group or HLA incompatible transplantation, we analyzed the interaction between complement, inflammation and coagulation, and signal pathway at an endothelial cell level. Blood group A/B antigen-expressing endothelial cells were established by gene transfer. Suppression of ERK pathway by anti A/B antibody and activation of PI3K/Akt pathway by HLA antibody were found to elicit up-regulation of cytoprotective factors. Human thrombomodulin which has the action for controlling coagulation and reducing inflammation, was proven to be useful in xenotransplantation. Obtained results from this research provide the valuable information on the strategy against antibody-mediated rejection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COAGULATION CONTROL USING GENE TRANSFER OF HUMAN DAF AND THROMBOMODULIN IN PIG TO PRIMATE XENOTRANSPLANTATION
在猪至灵长类动物异种移植中使用人 DAF 和血栓调节蛋白基因转移进行凝血控制
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Miwa Y, Kobayashi T, et al.]
通讯作者: et al.
DOI: 10.1097/tp.0b013e3181ffbab4
发表时间: 2011-01-27
期刊: TRANSPLANTATION
影响因子: 6.2
作者: [Iwase, Hayato, Kobayashi, Takaaki, Nakao, Akimasa]
通讯作者: Nakao, Akimasa
DOI: 10.1016/j.trim.2008.09.007
发表时间: 2009-01-01
期刊: TRANSPLANT IMMUNOLOGY
影响因子: 1.5
作者: [Kobayashi, Takaaki, Liu, DaGe, Nakao, Akimasa]
通讯作者: Nakao, Akimasa
Successful ABO-Incompatible Kidney Transplantation with Low Dose Rituximab for Standard Risk Patients and without Rituximab/Splenectomy for Low Risk Patients.
对于标准风险患者使用低剂量利妥昔单抗成功进行 ABO 不相容肾移植,对于低风险患者不使用利妥昔单抗/脾切除术。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Watarai Y, Kobayashi T, et al.]
通讯作者: et al.
46
    Diversity analysis of antibody function and development of strategy to overcome antibody-mediate rejection: Establishment of pig model for ABO/HLA-incompatibility
    • 批准号:
      15K15472
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      KOBAYASHI Takaaki
    • 依托单位:
    Comprehensive study on control of chronic antibody-mediated rejection after renal transplantation
    Development of in vitro culture for peripheral B cell differentiation into plasma cell
    • 批准号:
      24659587
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      KOBAYASHI Takaaki
    • 依托单位:
    Analysis of the invasive capacity at the invasive front of colon cancer, using crypt isolation technique and microarray
    • 批准号:
      21791305
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2009
    • 负责人:
      KOBAYASHI Takaaki
    • 依托单位:
    海外基金